Clinical and Technical Characteristics of Coronary Angiography and Percutaneous Coronary Interventions Performed before and after Transcatheter Aortic Valve Replacement with a Balloon-Expandable Valve
Table 1
Baseline clinical characteristics and TAVR procedural data from the coronary angiogram group and the PCI group.
Angiogram group (n = 28)
PCI group (n = 13)
Clinical characteristics
Age (years)
72.54 ± 9.08
70.31 ± 7.99
Male
14 (50.0)
9 (69.2)
Body mass index (kg/m2)
28.94 ± 5.96
28.63 ± 5.38
NYHA functional class III-IV
17 (60.7)
6 (46.2)
Diabetes
13 (46.4)
5 (38.5)
Hypertension
24 (85.7)
13 (100)
Coronary artery disease
23 (82.1)
13 (100)
Prior percutaneous coronary intervention
15 (53.6)
13 (100)
Prior coronary arterial bypass graft
14 (50.0)
9 (69.2)
History of atrial fibrillation
4 (14.3)
3 (23.1)
Peripheral vascular disease
9 (32.1)
7 (53.8)
Chronic obstructive pulmonary disease
7 (25.0)
5 (38.5)
Chronic kidney disease
15 (53.6)
10 (76.9)
eGFR (mL/min)
60.36 ± 24.63
58.47 ± 26.01
STS-PROM (%)
5.25 ± 2.71
5.89 ± 3.06
LogEuroSCORE (%)
17.22 ± 11.79
17.45 ± 12.72
Left coronary height (mm)
12.77 ± 3.27
12.32 ± 2.72
Right coronary height (mm)
13.23 ± 3.20
14.50 ± 4.59
Aortoventricular angulation (degrees)
42.40 ± 7.97
43.30 ± 7.50
Procedural characteristics
Success
28 (100)
13 (100)
Approach
Transfemoral
8 (28.6)
4 (30.8)
Nontransfemoral
20 (71.4)
9 (69.2)
Prothesis type
Edwards-SAPIEN
12 (42.9)
6 (46.2)
SAPIEN XT
16 (57.1)
7 (53.8)
Prothesis size (mm)
23
15 (53.6)
5 (38.5)
26
11 (39.3)
6 (46.2)
29
2 (7.1)
2 (15.4)
THV-coronary ostia position
Supra-ostial
5 (17.8)
3 (23.0)
Ostial level
8 (28.6)
5 (38.5)
Infra-ostial
15 (53.6)
5 (38.5)
Variables are expressed as n (%) or mean ± SD. eGFR = estimated glomerular filtration rate; LogEuroSCORE = logistic EuroSCORE predicted risk of mortality; NYHA = New York Heart Association; STS-PROM = Society of Thoracic Surgeons Predicted Risk of Mortality; THV = transcatheter heart valve.
